Close Menu

glaucoma

With UK Biobank and FinnGenn data, researchers tracked down rare changes in the angiopoietin-like 7 gene that coincide with lower glaucoma and intraocular pressure risk.

In PLOS this week: gene alteration linked to glaucoma, genome sequencing traces origin of lager yeast, and more.

The new PRS could help identify people at increased risk who may benefit from earlier screening and treatment to prevent blindness.

The test will be designed to detect a protein biomarker in aqueous humor that can be used to determine the severity of glaucoma and to make treatment decisions.

Through a meta-analysis of nearly 140,000 people, an international team of researchers tied 112 loci to increased intraocular pressure, a glaucoma risk factor.

The biomarker has been associated with retinal ganglion cell death and is upregulated in mouse models of chronic glaucoma.

In PNAS this week: innate immune interactions with TB bug, cytoplasmic microtubule organizing center-like structure, and more.

Researchers have used the gene-editing tool to disrupt a gain-of-function mutation in mice and human tissues that leads to glaucoma.

Researchers linked loci near three genes, including one involved in limiting oxidative damage, to primary open-angle glaucoma susceptibility.

Through genetic association and functional studies, researchers from the University of California, San Diego found that risk variants in SIX6 and p16INK4a are associated with senescence of retinal ganglion cells.

Pages

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.